Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Hillstream BioPharma
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
February 14, 2022
From
Hillstream BioPharma
Via
AccessWire
Tickers
HILS
SAVE THE DATES: Hillstream BioPharma Announces R&D Day on February 24, 2022 and Business Review on Monday February 14, 2022
February 11, 2022
From
Hillstream BioPharma
Via
AccessWire
Tickers
HILS
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression
February 01, 2022
From
Hillstream BioPharma
Via
AccessWire
Tickers
HILS
Hillstream BioPharma and University of Massachusetts Chan Medical School Announce Research Collaboration using CRISPR and Computational Approaches to Advance The Hillstream Ferroptomic Atlas
January 26, 2022
From
Hillstream BioPharma
Via
AccessWire
Tickers
HILS
Hillstream BioPharma Announces Closing of Initial Public Offering
January 14, 2022
From
Hillstream BioPharma
Via
AccessWire
Tickers
HILS
Hillstream BioPharma Announces Pricing of Initial Public Offering
January 11, 2022
From
Hillstream BioPharma
Via
AccessWire
Tickers
HILS
Hillstream BioPharma and Minotaur Therapeutics Sign Term Sheet to Advance Next-Generation Targeted Knob Biologics for Undruggable Targets
August 05, 2021
From
Hillstream BioPharma
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D.
July 13, 2021
From
Hillstream BioPharma
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Hillstream BioPharma Announces Abstract at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Highlighting HSB-1216’s Effect in Triple Negative Breast Cancer (TNBC)
June 02, 2021
From
Hillstream BioPharma
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.